NCT06358599View on ClinicalTrials.gov

The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy

CompletedOBSERVATIONAL
Enrollment

221

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

October 20, 2023

Study Completion Date

January 15, 2024

Conditions
Bladder CancerBladder Cancer Stage IBladder Cancer Stage II
Interventions
DRUG

Cisplatin

Neoadjuvant cisplatin-containing combination chemotherapy was defined as the receipt of multiagent systemic chemotherapy initiated within 6 months prior to the date of radical cystectomy

Trial Locations (1)

06170

Ankara Etlik City Hospital, Ankara

All Listed Sponsors
lead

Ankara Etlik City Hospital

OTHER_GOV

NCT06358599 - The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy | Biotech Hunter | Biotech Hunter